Skip to content
StockMarketAgent
Direct answer
ORCL trades against a final fair-value range of $188.36-$282.14, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $188, high $282, with mid-point at $234.
Stock analysis

ORCL fair value $188–$282

By StockMarketAgent.AI team· supervised by
Analizado: 2026-05-07Próxima actualización: 2026-08-07Methodology v2.5Review: automatedArchetype: Mature compounder
View archive
Precio
$194.59
▲ +39.43 (+20.26%)
Valor razonable
$234
$188–$282
Calificación
Comprar
confidence 88/100
Potencial alcista
+20.3%
upside to fair value
Margen de seguridad
$198.92
MoS level · 15%
Capitalización bursátil
$559.6B
P/E fwd 24.2
Respaldo en inglésES
Mostrando la fuente en inglés mientras traducimos
Este informe aún no se ha traducido. Actualice en unos minutos una vez que la cola de traducción se ponga al día.

§1 Resumen ejecutivo

  • Composite fair value $234 with high case $282.
  • Implied upside of 20.3% to fair value.
  • Moat 9/10 · confidence 88/100 · Mature compounder.
  • Trades below fair value with a meaningful cushion to the midpoint.
Fair value
$234
Margin of safety
+16.8%
Confidence
88/100
Moat
9/10

Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.

$194.59Price
Low $188.36
Mid $234.02
High $282.14

ORCL trades against a final fair-value range of $188.36-$282.14, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • Massive, sticky enterprise database install
    Massive, sticky enterprise database install base with extreme switching costs.
  • Integrated Generation 2 Cloud (OCI)
    Integrated Generation 2 Cloud (OCI) capturing emerging AI workloads.
  • Bull thesis
    Valuation models heavily favor forward-looking earnings over the near-term FCF distortion caused by AI CapEx.

§2 Caso bajista

A heavy capital expenditureCapital expendituresCash spent on acquiring or upgrading property, plant, and equipment. Splits into maintenance capex (sustaining current capacity) and growth capex (expanding capacity). cycle yields lower-than-expected ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created.. FCFFree cash flowOperating cash flow minus capital expenditures. The cash a business generates after maintaining and growing its asset base — the closest accounting proxy for owner-economics. remains severely depressed as CapExCapital expendituresCash spent on acquiring or upgrading property, plant, and equipment. Splits into maintenance capex (sustaining current capacity) and growth capex (expanding capacity). scales, while legacy on-premise revenueRevenueRevenue is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions. deteriorates faster than OCI growth can offset, stressing the $104B debt load.

Cómo puede fallar esta tesis

Hyperscaler Margin War

· Medium

Dominant hyperscalers aggressively slash AI workload pricing, permanently compressing OCI's structural gross margins.

FV impact
-25%
Trigger
12-24 Months

Debt Overhang Paralysis

· Low

Prolonged high interest rates combined with $104B in debt restricts operational agility and forces dilutive equity raises.

FV impact
-15%
Trigger
24-36 Months

Accelerated Legacy Attrition

· Low

Enterprise customers migrate off legacy Oracle databases to cheaper, cloud-native open-source alternatives faster than anticipated.

FV impact
-30%
Trigger
24-48 Months
Señales de alerta temprana a vigilar
MétricaActualUmbral de activación
OCI revenue growth decelerating below 25% year-over-year.MonitorDeterioration versus the report thesis
Cloud infrastructure gross margin contracting by over 200 bps.MonitorDeterioration versus the report thesis
CapEx-to-revenue ratio remaining above 20% well beyond the peak AI buildout.MonitorDeterioration versus the report thesis
Net debt-to-EBITDA ratio exceeding 4x.MonitorDeterioration versus the report thesis
Failure to realize guided Cerner integration synergies.MonitorDeterioration versus the report thesis

§3 Historial financiero

Cuenta de resultados — últimos seis períodos

Concepto2022-05-312023-05-312024-05-312025-05-31Trend
Ingresos$42.44B$49.95B+17.7%$52.96B+6.0%$57.40B+8.4%+10.6%
Beneficio bruto$33.56B$36.39B$37.82B$40.47B+6.4%
Beneficio operativo$15.83B$13.77B$16.07B$18.05B+4.5%
Beneficio neto$6.72B$8.50B+26.5%$10.47B+23.2%$12.44B+18.8%+22.8%
BPA (diluido)$2.41$3.07$3.71$4.34+21.7%
EBITDA$13.53B$18.74B$21.39B$23.91B+20.9%
I+D$7.22B$8.62B$8.92B$9.86B+11.0%
SG&A$9.36B$10.41B$9.82B$10.25B+3.1%

Puntuaciones de calidad

Piotroski F-score
5 / 9
Compuesto de calidad 0–9
Altman Z-score
2.41
Riesgo de quiebra (>3 seguro)
Beneish M-score
-2.56
Riesgo de manipulación de beneficios
OCF / Beneficio neto
1.67×
>1 indica alta calidad de los beneficios
Umbral de calidad contable
Pass
Umbral ajustado por sector
ROIC
10.6%
Rentabilidad del capital invertido
Suscriptores individuales — desde §411 secciones más

Leer el análisis completo — 11 secciones más.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Informe completo para cada ticker cubierto
24 meses de archivo de calificaciones
Briefings de lista de seguimiento + alertas de cambio de calificación
Exportación PDF + DOCX en cualquier idioma
Comenzar prueba gratuita
Cancela cuando quieras.
SCENARIOS FAQ

ORCL scenarios questions

  1. Each scenario for ORCL (ORCL) carries a five-year price target, an explicit set of assumptions (growth, terminal multiple, margin path), and a probability weight calibrated against current visibility.
FAQ

ORCL — frequently asked questions

  1. Based on our latest analysis, ORCL looks meaningfully undervalued. The current price is $195 versus a composite fair-value midpoint of $234 (range $188–$282), which implies roughly 20.3% upside to the midpoint.
Related coverage

Names readers of ORCL also follow

Same archetype: mature-compounder